Investigating the role of NPR1 in dilated cardiomyopathy and its potential as a therapeutic target for glucocorticoid therapy

• Published in: Frontiers in pharmacology Vol. 14; p. 1290253
• Main Authors: Huang, Yaomeng, Li, Tongxin, Gao, Shichao, Li, Shuyu, Zhu, Xiaoran, Li, Ying, Liu, Dangyang, Li, Weimin, Yang, Linquan, Liu, Kunshen, Zhang, Zheng, Liu, Chao
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 07.11.2023
• Subjects: dilated cardiomyopathy; glucocorticoid; natriuretic peptide receptor 1; SsGSEA; WGCNA
• ISSN: 1663-9812; 1663-9812
• DOI: 10.3389/fphar.2023.1290253

Background: Dilated cardiomyopathy (DCM), a specific form of cardiomyopathy, frequently presents clinically with either left ventricular or biventricular enlargement, often leading to progressive heart failure. In recent years, the application of bioinformatics technology to scrutinize the onset, progression, and prognosis of DCM has emerged as a fervent area of interest among scholars globally. Methods: In this study, core genes closely related to DCM were identified through bioinformatics analysis, including weighted gene co expression network analysis (WGCNA) and single sample gene set enrichment analysis (ssGSEA) and so on. The correlation was verified through experiments on DCM patients, DCM rat models, and core gene knockout mice. Subsequently, the effects of glucocorticoids on DCM and the regulation of core genes were observed. Result: In the present study, natriuretic peptide receptor 1 (NPR1) was identified as a core gene associated with DCM through WGCNA and ssGSEA. Significant impairment of cardiac and renal function was observed in both DCM patients and rats, concomitant with a notable reduction in NPR1 expression. NPR1 KO mice displayed symptomatic manifestations of DCM, underscoring the pivotal role of NPR1 in its pathogenesis. Notably, glucocorticoid treatment led to substantial improvements in cardiac and renal function, accompanied by an upregulation of NPR1 expression. Discussion: These findings highlight the critical involvement of NPR1 in the pathophysiology of DCM and its potential as a key target for glucocorticoid-based DCM therapy. The study provides a robust theoretical and experimental foundation for further investigations into DCM etiology and therapeutic strategies.